Coping and Communication Skills Training for Gynecologic Cancers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of the Journey Ahead intervention in helping individuals with gynecologic cancers enhance their coping and communication skills. Participants will engage in eight sessions and six phone calls focused on these skills. The program is designed for those diagnosed with specific types of gynecologic cancers, such as ovarian or cervical cancer, who have undergone treatment or surgery in the past five years. Participants must have internet access and be able to communicate in English to take part in online and phone sessions. As an unphased trial, this study offers a unique opportunity to contribute to research that could improve support for others facing similar challenges.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Journey Ahead intervention is safe for participants with gynecologic cancers?
Research has shown that the Journey Ahead program helps women with gynecologic cancers enhance their coping skills and communication. In a previous study, 14 women diagnosed and treated for these cancers participated in the Journey Ahead program. They completed eight online sessions, and no negative effects were reported, suggesting participants generally tolerate the program well.
As the program involves coaching sessions rather than medication or surgery, the risk of physical harm remains very low. It is designed to help participants manage stress and improve communication. Overall, evidence indicates that Journey Ahead is safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about the "Journey Ahead" program because it focuses on developing coping and communication skills specifically for individuals with gynecologic cancers. Unlike conventional treatments that might focus on medication or surgery, this intervention emphasizes psychological support through 8 sessions and 6 phone calls, potentially improving patients' mental well-being and quality of life. This approach is unique because it recognizes the importance of emotional and communicative strength in managing cancer, offering a holistic complement to standard medical treatments.
What evidence suggests that the Journey Ahead intervention is effective for improving coping and communication skills in gynecologic cancer patients?
Research shows that the Journey Ahead program, provided to participants in this trial, helps individuals with gynecologic cancers improve coping and communication skills. Studies have found that similar methods, such as cognitive-behavioral therapy, effectively reduce symptoms in women with these cancers. Early results suggest that Journey Ahead, which combines online and telehealth coaching, is practical and well-received by participants. While specific data on its effectiveness is still being gathered, the program relies on proven techniques to support emotional and social well-being.12367
Who Is on the Research Team?
Sharon L Manne, PhD
Principal Investigator
Rutgers Cancer Institute of New Jersey
Are You a Good Fit for This Trial?
This trial is for women over 18 who've been diagnosed with various gynecological cancers, including uterine, ovarian, and cervical cancer. Participants should be within 5 years post-cancer surgery or treatment like chemo or radiation and must have internet access to view online sessions.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants engage in the Journey Ahead intervention focusing on coping and communication skill development during the course of 8 sessions and 6 phone calls.
Follow-up
Participants are monitored for changes in distress, coping, and other psychological measures post-intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Journey Ahead
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor